Childhood myeloproliferative disorders

被引:1
|
作者
Cotter, FE [1 ]
机构
[1] Inst Child Hlth, Mol Haematol Unit, London WC1N 1EH, England
来源
BAILLIERES CLINICAL HAEMATOLOGY | 1998年 / 11卷 / 04期
关键词
myeloproliferation; paediatric; JCML; molecular genetics; chromosome; 7; FISH;
D O I
10.1016/S0950-3536(98)80044-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Disorders classified as paediatric myeloproliferative disorders (MPD), such as juvenile chronic myeloid leukaemia (JCML), and as paediatric myelodysplastic syndrome (MDS), are essentially diseases characterized by abnormal myeloproliferation and they share similar genetic events on chromosome 7. As such, the abnormalities of increased myeloproliferation in childhood (AIMC) should be considered under the same heading. Constitutional and other genetic factors play an essential role in children and include the NF1 gene, whereas toxic exposure is of greater importance in adults. The most common cytogenetic alteration is that of monosomy or deletion of the long arm of chromosome 7. Critical regions have been identified and mapped by fluorescence in situ hybridization (FISH). It appears that the similar critical regions on chromosome 7 are involved, and suggests that these regions may contain genes important in the pathogenesis of AIMC.
引用
收藏
页码:875 / 898
页数:24
相关论文
共 50 条
  • [1] Myelodysplastic and myeloproliferative disorders of childhood
    Hasle, Henrik
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 598 - 604
  • [2] Myelodysplasia and myeloproliferative disorders in childhood: An update
    Emanuel, PD
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 (04) : 852 - 863
  • [3] Myelodysplastic and myeloproliferative disorders of childhood: A study of 167 patients
    Luna-Fineman, S
    Shannon, KM
    Atwater, SK
    Davis, J
    Masterson, M
    Ortega, J
    Sanders, J
    Steinherz, P
    Weinberg, V
    Lange, BJ
    BLOOD, 1999, 93 (02) : 459 - 466
  • [4] Congenital and Childhood myeloproliferative disorders with eosinophilia responsive to imatinib
    Abraham, Shirley
    Salama, Mohamed
    Hancock, Jeffrey
    Jacobsen, Jeffrey
    Fluchel, Mark
    PEDIATRIC BLOOD & CANCER, 2012, 59 (05) : 928 - 929
  • [5] Cytogenetic and molecular genetic aspects of childhood myeloproliferative/myelodysplastic disorders
    Hall, GW
    ACTA HAEMATOLOGICA, 2002, 108 (04) : 171 - 179
  • [6] Disease characteristics and course of myeloproliferative disorders (MPDs) in childhood.
    Polychronopoulou, S
    Kostaridou, S
    Panagiotou, JP
    Rouli, V
    Parcharidou, A
    Sambani, C
    Tassidou, A
    Anagnostou, D
    Haidas, SA
    BLOOD, 2001, 98 (11) : 280B - 280B
  • [7] Myeloproliferative disorders
    Bench, AJ
    Cross, NCP
    Huntly, BJP
    Nacheva, EP
    Green, AR
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2001, 14 (03) : 531 - 551
  • [8] THE MYELOPROLIFERATIVE DISORDERS
    HUTCHISON, HE
    JOURNAL OF CLINICAL PATHOLOGY, 1959, 12 (04) : 380 - 380
  • [9] MYELOPROLIFERATIVE DISORDERS
    ROUSSO, C
    SCHWEIZERISCHE RUNDSCHAU FUR MEDIZIN PRAXIS, 1974, 63 (45): : 1335 - 1337
  • [10] Myeloproliferative disorders
    Levine, Ross L.
    Gilliland, D. Gary
    BLOOD, 2008, 112 (06) : 2190 - 2198